AMPEC4: Naja ashei Venom-Derived Peptide as a Stimulator of Fibroblast Migration with Antibacterial Activity
Molecules · 15.05.2025 · 30 (10) · 2167
DOI: 10.3390/molecules30102167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 15.05.2025. Verfasst von Ewa Ciszkowicz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Bioinformatics, Faculty of Chemistry, Rzeszów University of Technology, al. Powstańców Warszawy 6, 35-959 Rzeszów, Po…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Fibroblasts, Cell Movement, Elapid Venoms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minister of Science and Higher Education Republic of Poland.
Abstract (Originalsprache)
The treatment of proctological conditions, including hemorrhoids, anal fissures, and perianal abscesses, is often complicated by bacterial infections, particularly those involving multidrug-resistant Escherichia coli. This study presents the synthesis, characterization, and biological evaluation of the newly designed synthetic peptide AMPEC4, inspired by cytotoxin 5 from Naja ashei snake venom. AMPEC4 demonstrated potent antimicrobial properties with MIC values of 100 and 200 µg/mL, effectively inhibiting biofilm formation (up to 84%) and eradicating the pre-formed biofilm by up to 35%. The antibacterial activity of AMPEC4 was further supported by a membrane permeabilization assay, demonstrating its capacity to disrupt bacterial membrane integrity in a dose-dependent manner. Furthermore, AMPEC4 significantly promoted fibroblast migration, a critical step in tissue regeneration, while exhibiting notable biocompatibility, as evidenced by the absence of hemolytic, cytotoxic, and genotoxic effects. By addressing both infection control and tissue regeneration, AMPEC4 represents a promising therapeutic strategy for managing chronic wounds, particularly in the challenging environment of the anorectal region. Its ability to target Escherichia coli reference and clinical strains while accelerating the wound-healing process underscores its potential for future clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Bioinformatics, Faculty of Chemistry, Rzeszów University of Technology, al. Powstańców Warszawy 6, 35-959 Rzeszów, Poland.
- Doctoral School of the Rzeszów University of Technology, al. Powstańców Warszawy 12, 35-959 Rzeszów, Poland.
- Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, al. Gen. J. Hallera 107, 80-416 Gdańsk, Poland.
- Department of Analytical Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, al. Gen. J. Hallera 107, 80-416 Gdańsk, Poland.
ORCID-Profile: Ewa Ciszkowicz, Andrzej Łyskowski, Anna Nieczaj, Konrad K Hus, Karol Sikora, Damian Neubauer, Aleksandra Bocian
Förderung
- Minister of Science and Higher Education Republic of Poland
Zitieren
APA
Ciszkowicz, E., Miłoś, A., Łyskowski, A., Buczkowicz, J., Nieczaj, A., Lecka-Szlachta, K., Hus, K. K., Sikora, K., Neubauer, D., Bauer, M., Kamysz, W., & Bocian, A. (2025). AMPEC4: Naja ashei Venom-Derived Peptide as a Stimulator of Fibroblast Migration with Antibacterial Activity. Molecules, 30(10), 2167. https://doi.org/10.3390/molecules30102167
Vancouver
Ciszkowicz E, Miłoś A, Łyskowski A, Buczkowicz J, Nieczaj A, Lecka-Szlachta K, et al. AMPEC4: Naja ashei Venom-Derived Peptide as a Stimulator of Fibroblast Migration with Antibacterial Activity. Molecules. 2025;30(10):2167. doi:10.3390/molecules30102167
BibTeX
@article{Ciszkowicz2025,
author = {Ciszkowicz, Ewa and Miłoś, Anna and Łyskowski, Andrzej and Buczkowicz, Justyna and Nieczaj, Anna and Lecka-Szlachta, Katarzyna and Hus, Konrad K and Sikora, Karol and Neubauer, Damian and Bauer, Marta and Kamysz, Wojciech and Bocian, Aleksandra},
title = {AMPEC4: Naja ashei Venom-Derived Peptide as a Stimulator of Fibroblast Migration with Antibacterial Activity},
journal = {Molecules},
year = {2025},
volume = {30},
number = {10},
pages = {2167},
doi = {10.3390/molecules30102167}
}
EUVIMED